DCAI Insider Trading Activity and SEC Form 4 Filings
DCAI insider trading summary
No open-market insider purchases or sales of Dialysis Corp of America (DCAI) have been reported on SEC Form 4 in the past 12 months.
Latest DCAI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 1, 2009 | Alexander Bienenstock | Director | Sell | $10K (2,000 @ $5.20) |
| May 29, 2009 | Joanne Zimmerman | VP, Clinical Services | Buy | $5K (1,000 @ $4.60) |
| May 15, 2009 | Thomas Patrick Carey | VP, Operations | Buy | $11K (2,500 @ $4.45) |
| May 15, 2009 | Thomas Patrick Carey | VP, Operations | Buy | $961 (218 @ $4.41) |
| May 15, 2009 | Thomas Patrick Carey | VP, Operations | Buy | $1K (300 @ $4.40) |
| May 15, 2009 | Stephen W Everett | President & CEO | Buy | $7K (1,500 @ $4.55) |
| May 15, 2009 | Thomas Patrick Carey | VP, Operations | Buy | $2K (482 @ $4.42) |
| May 14, 2009 | Joanne Zimmerman | VP, Clinical Services | Buy | $3K (700 @ $4.38) |
| Jun 24, 2008 | Thomas Patrick Carey | Vice President, Operations | Buy | $4K (600 @ $7.17) |
| Jun 24, 2008 | Thomas Patrick Carey | Vice President, Operations | Buy | $7K (900 @ $7.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.